| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.3B | $6.4B | $6.2B | $6.2B | $5.8B | $1.4B | $1.6B | $1.6B |
| Cost of Revenue | $2.4B | $2.5B | $2.7B | $2.6B | $2.4B | $0.6B | $0.7B | — |
| Gross Profit | $3.9B | $3.8B | $3.5B | $3.5B | $3.3B | $0.8B | $0.9B | $0.8B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.2B | $3.2B | $3.1B | $2.9B | $2.7B | $0.7B | $0.7B | $0.7B |
| Operating Income | $0.7B | $0.3B | $0.4B | $0.6B | $0.7B | $0.1B | $0.1B | $0.1B |
| Net Income | $0.6B | $0.2B | $0.2B | $0.6B | $0.6B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $1.46 | $0.53 | $0.63 | $1.43 | $1.38 | $0.14 | $0.24 | — |
| EPS (Diluted) | $1.45 | $0.52 | $0.62 | $1.41 | $1.35 | $0.14 | $0.23 | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.8B | $6.4B | $6.1B | $6.0B | $5.9B | $5.6B | $4.2B | $3.5B |
| Current Assets | $3.2B | $2.9B | $2.6B | $2.8B | $2.7B | $3.1B | $2.9B | $2.3B |
| Cash & Equivalents | $0.8B | $0.7B | $0.4B | $0.4B | $0.8B | $1.5B | $0.9B | $0.7B |
| Total Liabilities | $4.6B | $4.4B | $4.0B | $4.1B | $4.2B | $4.3B | $2.7B | $2.6B |
| Current Liabilities | $2.0B | $2.0B | $1.8B | $2.0B | $1.9B | $1.5B | $1.2B | $1.1B |
| Stockholders' Equity | $2.3B | $2.0B | $2.0B | — | — | $1.3B | $1.6B | $0.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.9B | $0.4B | $0.2B | $0.7B | $0.5B | $0.4B | $0.4B |
| Investing Cash Flow | $-0.1B | $-0.3B | $-0.2B | $-0.2B | $-0.6B | $-0.2B | $-0.2B | $-0.2B |
| Capital Expenditures | $0.2B | $0.2B | $0.3B | $0.3B | $0.2B | $0.1B | $0.2B | $0.2B |
| Financing Cash Flow | $-0.4B | $-0.3B | $-0.2B | $-0.4B | $-0.8B | $0.3B | $0.1B | $-0.1B |